CU6 clarity pharmaceuticals ltd

Pardon my ignorance in this area @ttppxx, you refer to "how the...

  1. 3,240 Posts.
    lightbulb Created with Sketch. 722
    Pardon my ignorance in this area @ttppxx, you refer to "how the COBRA Reference Standard was constructed" in reation to "A positive 64Cu-SAR-bisPSMA scan shall be considered a False Positive if the Reference standard is Negative".

    Which party constructs the Reference Standard for a trial? I assumed it was Clarity itself.

    If so, wouldn't the decision to allocate a scan as False Positive if the Reference standard is Negative just be a matter of taking a conservative approach?

    Doesn't this effectively render the trial almost useless. I suppose it tests whether the trialled product is as good, just not whether it's better?

    Thanks, appreciate your contribution here
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.09
Change
0.000(0.00%)
Mkt cap ! $671.8M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 48 $2.22
 

Sellers (Offers)

Price($) Vol. No.
$1.96 28 1
View Market Depth
Last trade - 09.44am 26/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.